Best practices and models
-
Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
This intellectual property landscapes tool developed in the MENA region can be used to assess the patent landscape in other countries.
-
Global Summit on IP and Access to Medicines – 2018
All the presentations from our inaugural GSIPA2M in Marrakech, January 2018.
-
The Roadmap – Special Edition Report on Dolutegravir
The Initiative for Medicines, Access and Knowledge (I-MAK), has published a special edition ‘Roadmap report’ on dolutegravir. The report provides...
-
Public Health Related Trips-Plus Provisions in Bilateral Trade Agreements
This policy guide highlights the adverse effects of bilateral trade agreements on public health and access to medicines in the...